Conotoxins and Drug Discovery with Special Reference to Hainan Species

Sulan Luo,Xiaopeng Zhu,Yong Wu,Dongting Zhangsun
DOI: https://doi.org/10.1007/978-94-007-6452-1_21
2017-01-01
Abstract:Cone snails native to tropical marine waters are unique as they have ability to use various small disulfide-bridged peptides (conotoxins or conopeptides, CTxs) for prey capture. So far conotoxins have attracted much interest as neuropharmacological tools, as potential leads in drug development, or indeed as drugs themselves due to their high potency and specificity for a range of important physiological targets. Given that up to 700 species of cone snails exist in the world and over >1000 peptides are present in each species, it is estimated that more than 500,000 conotoxins may await discovery. This natural library of bioactive peptides thus provides a rich source of potential drug leads or neurophysiological probes. Less than 0.1% of this diverse library of compounds has been examined. Cone snails native to Hainan are unique biological resources of marine drugs in China. Conotoxins adopt a variety of 3D structures and can be regarded as "mini-proteins." They range from simple helical structures for non-disulfide-bonded conopeptides to tightly folded structures with cross-bracing disulfide bonds for the cystine-rich conotoxins. In general, this type of structural motif provides conotoxins with high stability compared with non-disulfide-bonded peptides. The structure and biological function of most conotoxins has not yet been defined, especially for Hainan Conus species. This chapter discusses Hainan conotoxins and drug discovery including their diversity, synthesis, structure-activity relationships, pharmacology, and therapeutic potential.
What problem does this paper attempt to address?